Xiaomo Xiong

584 total citations
23 papers, 352 citations indexed

About

Xiaomo Xiong is a scholar working on Economics and Econometrics, Epidemiology and Infectious Diseases. According to data from OpenAlex, Xiaomo Xiong has authored 23 papers receiving a total of 352 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Economics and Econometrics, 7 papers in Epidemiology and 3 papers in Infectious Diseases. Recurrent topics in Xiaomo Xiong's work include Health Systems, Economic Evaluations, Quality of Life (9 papers), Pharmaceutical Economics and Policy (4 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). Xiaomo Xiong is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (9 papers), Pharmaceutical Economics and Policy (4 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). Xiaomo Xiong collaborates with scholars based in United States, China and Macao. Xiaomo Xiong's co-authors include Jing Yuan, Kevin Lu, Minghui Li, Bin Jiang, Aixia Ma, Ting Zhou, Haijing Guan, Gang Lv, Yang Liu and Renyu Liu and has published in prestigious journals such as Quality of Life Research, Frontiers in Pharmacology and BMJ Open.

In The Last Decade

Xiaomo Xiong

21 papers receiving 348 citations

Peers

Xiaomo Xiong
Xinyang Hua Australia
Maxwell Birger United States
Chandra J. Cohen-Stavi Israel
J. Wise United States
Aziz Rezapour Iran
Francesca Bravi Italy
Qi Cao Netherlands
Rasha M. Arabyat Jordan
Edward C. Mansley United States
Fahad Alamri Saudi Arabia
Xinyang Hua Australia
Xiaomo Xiong
Citations per year, relative to Xiaomo Xiong Xiaomo Xiong (= 1×) peers Xinyang Hua

Countries citing papers authored by Xiaomo Xiong

Since Specialization
Citations

This map shows the geographic impact of Xiaomo Xiong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaomo Xiong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaomo Xiong more than expected).

Fields of papers citing papers by Xiaomo Xiong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaomo Xiong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaomo Xiong. The network helps show where Xiaomo Xiong may publish in the future.

Co-authorship network of co-authors of Xiaomo Xiong

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaomo Xiong. A scholar is included among the top collaborators of Xiaomo Xiong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaomo Xiong. Xiaomo Xiong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lv, Gang, Xiangxiang Jiang, Xiaomo Xiong, et al.. (2025). Economic outcomes of diabetes self-management education among older Medicare beneficiaries with diabetes. BMC Health Services Research. 25(1). 686–686. 1 indexed citations
2.
3.
DiBello, Julia, Xiaomo Xiong, Xinyue Liu, et al.. (2025). Trajectories of pharmacological therapies for treatment-resistant depression: a longitudinal study. BMC Psychiatry. 25(1). 215–215. 1 indexed citations
4.
Xiong, Xiaomo & Jeff J. Guo. (2024). Cost Effectiveness of Tremelimumab Plus Durvalumab for Unresectable Hepatocellular Carcinoma in the USA. PharmacoEconomics. 43(3). 271–282. 1 indexed citations
5.
Lu, Kevin, Xiaomo Xiong, Minghui Li, et al.. (2023). Trends in prevalence, health disparities, and early detection of dementia: A 10-year nationally representative serial cross-sectional and cohort study. Frontiers in Public Health. 10. 1021010–1021010. 7 indexed citations
6.
Yuan, Jing, Kevin Lu, Xiaomo Xiong, et al.. (2023). Age and geographic disparities in acute ischaemic stroke prehospital delays in China: a cross-sectional study using national stroke registry data. The Lancet Regional Health - Western Pacific. 33. 100693–100693. 13 indexed citations
7.
Yuan, Jing, et al.. (2022). Impact of National Volume-Based Procurement on the Procurement Volumes and Spending for Antiviral Medications of Hepatitis B Virus. Frontiers in Pharmacology. 13. 842944–842944. 10 indexed citations
8.
Xiong, Xiaomo, et al.. (2022). CO76 Hypertension and the Risk of Dementia Among Medicare Beneficiaries in the U.S.. Value in Health. 25(7). S318–S318.
9.
Xiong, Xiaomo, et al.. (2022). Evidence of Chinese Herbal Medicine Use From an Economic Perspective: A Systematic Review of Pharmacoeconomics Studies Over Two Decades. Frontiers in Pharmacology. 13. 765226–765226. 5 indexed citations
10.
Lu, Kevin, et al.. (2022). Corrigendum: Big Data and Real-World Data Based Cost-Effectiveness Studies and Decision-Making Models: A Systematic Review and Analysis. Frontiers in Pharmacology. 12. 833827–833827. 1 indexed citations
11.
Zhang, Weiwei, Gang Lv, Xiaomo Xiong, & Minghui Li. (2021). Effect of Cost-Related Medication Non-adherence Among Older Adults With Medication Therapy Management. Frontiers in Medicine. 8. 670034–670034. 1 indexed citations
12.
Xiong, Xiaomo, Jing Yuan, Minghui Li, Bin Jiang, & Kevin Lu. (2021). Age and Gender Disparities in Adverse Events Following COVID-19 Vaccination: Real-World Evidence Based on Big Data for Risk Management. Frontiers in Medicine. 8. 700014–700014. 49 indexed citations
13.
Lu, Kevin, et al.. (2021). Big Data and Real-World Data based Cost-Effectiveness Studies and Decision-making Models: A Systematic Review and Analysis. Frontiers in Pharmacology. 12. 700012–700012. 3 indexed citations
14.
15.
Lv, Gang, Jing Yuan, Xiaomo Xiong, & Minghui Li. (2021). Mortality Rate and Characteristics of Deaths Following COVID-19 Vaccination. Frontiers in Medicine. 8. 670370–670370. 44 indexed citations
16.
17.
Yuan, Jing, Kevin Lu, Xiaomo Xiong, & Bin Jiang. (2021). Lowering drug prices and enhancing pharmaceutical affordability: an analysis of the national volume-based procurement (NVBP) effect in China. BMJ Global Health. 6(9). e005519–e005519. 68 indexed citations
18.
Li, Minghui, et al.. (2021). Trend and effects of high-deductible health insurance plans in the health care system: financial access problems in management of cognitive impairment. Journal of Managed Care & Specialty Pharmacy. 28(1). 7–15. 2 indexed citations
19.
Xiong, Xiaomo, et al.. (2020). Cost-Effectiveness of Tofacitinib for Patients with Moderate-to-Severe Rheumatoid Arthritis in China. PharmacoEconomics. 38(12). 1345–1358. 13 indexed citations
20.
Zhou, Ting, et al.. (2018). The quality of life in Chinese population with chronic non-communicable diseases according to EQ-5D-3L: a systematic review. Quality of Life Research. 27(11). 2799–2814. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xinyang Hua Breakdown of academic impact, for papers by Maxwell Birger Breakdown of academic impact, for papers by Chandra J. Cohen-Stavi Breakdown of academic impact, for papers by J. Wise Breakdown of academic impact, for papers by Aziz Rezapour Breakdown of academic impact, for papers by Francesca Bravi Breakdown of academic impact, for papers by Qi Cao Breakdown of academic impact, for papers by Rasha M. Arabyat Breakdown of academic impact, for papers by Edward C. Mansley Breakdown of academic impact, for papers by Fahad Alamri
Rankless by CCL
2026